Literature DB >> 12040177

B cell antigen receptor signaling: roles in cell development and disease.

Stephen B Gauld1, Joseph M Dal Porto, John C Cambier.   

Abstract

Signals propagated through the B cell antigen receptor (BCR) are vital for the development and survival of B lymphocytes in both the bone marrow and the periphery. These signals not only guide maturation and activation but also affect the removal of potentially self-reactive B lymphocytes. Interestingly, these signals are known to be either ligand-independent ("tonic" signals) or induced by ligand (antigen) binding to the BCR. We focus on the problems that occur in B cell development due to defects in signals emanating from the BCR. In addition, we present the B Cell Antigen Receptor Pathway, an STKE Connections Map that illustrates the events involved in B cell signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040177     DOI: 10.1126/science.1071546

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  71 in total

1.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors.

Authors:  Lela Kardava; Susan Moir; Wei Wang; Jason Ho; Clarisa M Buckner; Jacqueline G Posada; Marie A O'Shea; Gregg Roby; Jenny Chen; Hae Won Sohn; Tae-Wook Chun; Susan K Pierce; Anthony S Fauci
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  B cells: new ways to inhibit their function in rheumatoid arthritis.

Authors:  Robert H Carter
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

3.  A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Authors:  Shuling Guo; Gregory Z Ferl; Rajendar Deora; Mireille Riedinger; Sheng Yin; James L Kerwin; Joseph A Loo; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

Review 4.  B cell signalling as therapeutic target.

Authors:  R H Carter
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

5.  Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma.

Authors:  Murali Janakiram; Venu K Thirukonda; Matthew Sullivan; Adam M Petrich
Journal:  Curr Treat Options Oncol       Date:  2012-02-02

6.  Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.

Authors:  Sergei Radaev; Zhongcheng Zou; Pavel Tolar; Khanh Nguyen; AnhThao Nguyen; Peter D Krueger; Nicole Stutzman; Susan Pierce; Peter D Sun
Journal:  Structure       Date:  2010-08-11       Impact factor: 5.006

Review 7.  The Vav family: at the crossroads of signaling pathways.

Authors:  Wojciech Swat; Keiko Fujikawa
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 8.  Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

Authors:  Mark Roschewski; Louis M Staudt; Wyndham H Wilson
Journal:  Nat Rev Clin Oncol       Date:  2013-11-12       Impact factor: 66.675

Review 9.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 10.  Protein kinase inhibitors against malignant lymphoma.

Authors:  Osmond J D'Cruz; Fatih M Uckun
Journal:  Expert Opin Pharmacother       Date:  2013-04       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.